Abeona Therapeutics (ABEO) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $207.5 million.
- Abeona Therapeutics' Cash & Current Investments rose 8852.86% to $207.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.5 million, marking a year-over-year increase of 8852.86%. This contributed to the annual value of $98.1 million for FY2024, which is 8654.97% up from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Cash & Current Investments is $207.5 million, which was up 8852.86% from $225.9 million recorded in Q2 2025.
- Abeona Therapeutics' 5-year Cash & Current Investments high stood at $225.9 million for Q2 2025, and its period low was $23.5 million during Q3 2022.
- Over the past 5 years, Abeona Therapeutics' median Cash & Current Investments value was $62.7 million (recorded in 2024), while the average stood at $83.6 million.
- In the last 5 years, Abeona Therapeutics' Cash & Current Investments tumbled by 6690.99% in 2022 and then soared by 23157.1% in 2024.
- Quarter analysis of 5 years shows Abeona Therapeutics' Cash & Current Investments stood at $50.9 million in 2021, then increased by 3.09% to $52.5 million in 2022, then grew by 0.15% to $52.6 million in 2023, then surged by 86.55% to $98.1 million in 2024, then skyrocketed by 111.56% to $207.5 million in 2025.
- Its last three reported values are $207.5 million in Q3 2025, $225.9 million for Q2 2025, and $152.7 million during Q1 2025.